Entegris Reveals Life Sciences Innovations Inspired by Semiconductor Industry at INTERPHEX 2021

Entegris to reveal lessons from semiconductor industry that have the potential to transform production and storage of drug subtances

PUBLISHED Oct. 14, 2021 | NEWS RELEASE
News Release
Download PDF (198.4 kB)

Billerica, MA, October 14, 2021Entegris, Inc. (NASDAQ: ENTG), a world-class supplier of advanced materials and process solutions for the semiconductor and other high-technology industries, today announced that the company will showcase its innovations for life sciences customers at Booth #1145 at the INTERPHEX 2021 conference. The event will take place at the Javits Center in New York City October 19 – 21, 2021.

At the Entegris booth, conference attendees will have the opportunity to view and evaluate the company’s Aramus™ 2D single-use bag assemblies, a preferred solution for freezing, transporting, storing, and thawing drug substances.

John Lynch, vice president of Life Sciences at Entegris, will present lessons learned in healthcare during the COVID-19 vaccine ramp-up from a semiconductor company and predictions for the future of the life sciences industry. Lynch’s presentation will detail learnings such as contamination reduction, advanced materials, and digitalization of the supply chain. His presentation will be on Tuesday, October 19 from 1:15 – 2:00 PM EST at Stage 2.

“The Entegris Life Sciences team has achieved many major milestones over the past 18 months as we rapidly mobilized to support pandemic needs,” said Lynch. “We are excited to be back at INTERPHEX this year to share our story with some of the brightest minds in the industry. Our more than 50 years of experience of working in complex and challenging manufacturing environments has helped us identify applicable lessons that can translate to life sciences.”

Entegris’ Aramus™ 2D single-use bag assemblies have highly innovative attributes, which make them a preferred solution for freezing, transporting, storing, and thawing drug substances, like COVID-19 vaccines. They are designed to be resistant to extreme cold temperatures and to withstand gamma sterilization. Many leading biopharma companies have expressed strong interest in using this innovation and several customers are currently incorporating it into their production.

To learn about how Entegris is supporting the life sciences sector, visit lifesciences.entegris.com.

About Entegris

Entegris is a world-class supplier of advanced materials and process solutions for the semiconductor and other high-technology industries. Entegris has approximately 6,600 employees throughout its global operations and is ISO 9001 certified. It has manufacturing, customer service, and/or research facilities in the United States, Canada, China, France, Germany, Israel, Japan, Malaysia, Singapore, South Korea, and Taiwan. Additional information may be found at www.entegris.com.

Forward-Looking Statements
This news release contains forward-looking statements. The words “believe,” “expect,” “anticipate,” “intend,” “estimate,” “forecast,” “project,” “should,” “may,” “will,” “would” or the negative thereof and similar expressions are intended to identify such forward-looking statements. These forward-looking statements include statements related to Entegris’ presentation at the INTERPHEX 2021 conference; applications for Entegris’ technologies; and other matters. These statements involve risks and uncertainties, and actual results may differ materially from those projected in the forward-looking statements.  These risks and uncertainties include, but are not limited to, those risk factors and additional information described in Entegris’ filings with the Securities and Exchange Commission, including under the heading “Risk Factors” in Item 1A of Entegris’ Annual Report on Form 10-K for the fiscal year ended December 31, 2020, filed with the Securities and Exchange Commission on February 5, 2021, and in Entegris’ other periodic filings.

About INTERPHEX
For 42 years, INTERPHEX has been, and continues to be, the premier pharmaceutical, biotechnology, and device development and manufacturing event where you can “Experience Science through Commercialization.” Sponsored by the Parenteral Drug Association (PDA), the event is based in New York and brings over 10,000 global industry professionals and 625+ industry leading suppliers. INTERPHEX offers annual domestic and international industry events and educational opportunities around the world. INTERPHEX and INNOPHEX together, offer the very latest intelligence, cutting-edge technologies and state-of-the-art innovation throughout the product development life cycle.

Media Contact:
Connie Chandler
Director of Corporate Communications
T +1 978-436-6546
connie.chandler@entegris.com

Investor Contact:
Bill Seymour
VP of Investor Relations
T +1 952-556-1844
bill.seymour@entegris.com